Skip to main content
. 2020 Oct 26;56(4):818–827. doi: 10.1038/s41409-020-01092-x

Table 2.

Etiologies of the documented infections by time period.

Pre-engraftment (≤30days) Intermediate and Late (>30days)
Only frequencies are shown in parenthesis HaploSCT
(n = 40)
MRD/VUD/MMUD
(n = 77)
HaploSCT
(n = 38)
MRD/VUD/MMUD
(n = 70)
Patients with ≥1 severe infection 18 (45) 31 (40) 6 (16) 22 (31)
Bacterial infections 23 37 10 33
Staphylococcus spp 7 17 2 4
Coagulase negative 7 15 2 4
Enterococcus spp 3 3 4
Streptococcus spp 3 5 3 5
S. pneumoniae 2 4
Gram-negative bacteria 9 10 4 13
C. difficile colitis 1 1 1 5
Other 1 2
IFI 2 3 1 4
IPA 2 2 1 2
Other 1 2
Viral infections 14 6 49 73
CMV
Reactivation 7 4 17 29
Disease 1
EBV 3
Reactivation 3
PTLPD
HSV or VZV 4 6
HHV-6 encephalitis 1 2
Viral haemorrhagic cystitis 4 1 8 5
Community‐acquired respiratory virus 2 1 14 27
Others (highlight) 2 4

MRD HLA-identical matched related donor, VUD HLA-matched volunteer unrelated donor, MMUR 1-allelel mismatched volunteer unrelated dono, CMV cytomegalovirus, EBV Epstein Barr virus, PTLPD post-transplant lymphoproliferative disorder, HVS Herpes simplex virus, VZV Varicella-zoster virus, HHV-6 Human herpesvirus 6, LRTI low respiratory tract infection.